Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
AbbVie
(NY:
ABBV
)
160.81
-0.91 (-0.56%)
Official Closing Price
Updated: 7:00 PM EDT, May 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AbbVie
< Previous
1
2
3
4
5
6
7
8
9
...
60
61
Next >
Powell And The Great Indecision
April 16, 2024
In today’s presser, Powell basically said what he typically says. Higher for longer but maybe not as risks remain to the economy while inflation is too sticky.
Via
Talk Markets
Topics
Economy
Exposures
Economy
Interest Rates
Steady Income, Steady Growth: 7 Blue-Chip Dividend Stocks to Buy Now
April 16, 2024
With an already tense situation becoming even more troubling, now’s the time to consider blue-chip dividend stocks to buy.
Via
InvestorPlace
Avalo Therapeutics' Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market, Analyst Upgrades
April 16, 2024
Unlock the potential of Avalo Therapeutics with AVTX-009, a promising drug for hidradenitis suppurativa. Oppenheimer upgrades to Outperform, foreseeing Phase 2 progress and market distinction.
Via
Benzinga
AbbVie's Options Frenzy: What You Need to Know
April 15, 2024
Via
Benzinga
Neumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug
April 15, 2024
The company was testing a potential treatment for schizophrenia in rabbits, but found a notable side effect.
Via
Investor's Business Daily
Is AbbVie a Millionaire Maker?
April 14, 2024
Everything is going according to plan, and more growth is on the way.
Via
The Motley Fool
Smart Money Is Betting Big In ABBV Options
April 12, 2024
Via
Benzinga
AbbVie Unusual Options Activity For April 05
April 05, 2024
Via
Benzinga
Smart Money Is Betting Big In ABBV Options
April 04, 2024
Via
Benzinga
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of AbbVie Inc. (ABBV) on Behalf of Investors
April 12, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
What's Going On AbbVie Stock On Friday?
April 12, 2024
AbbVie releases interim analysis on atogepant, an oral migraine prevention drug. Key findings show significant reductions in migraine days and consistent safety profile. Atogepant, known as Qulipta...
Via
Benzinga
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of AbbVie Inc. (ABBV) on Behalf of Investors
April 12, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024
April 11, 2024
In a stock picker’s market, here are three biotech stocks analysts believe have a chance to outperform the market in 2024.
Via
InvestorPlace
The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today
April 11, 2024
Vertex hopes Alpine's drug can be tested on other conditions beyond the one entering Phase 3 trial for a kidney disease.
Via
InvestorPlace
Blindness-Focused LENZ Therapeutics' Investigational Eye Drop Ready To Revolutionize Presbyopia Landscape, Analyst Says
April 10, 2024
Advances in presbyopia treatment with LENZ Therapeutics' LNZ100. Clinically proven to enhance near-vision for up to 10 hours, it offers a promising alternative to reading glasses. Analysts predict a...
Via
Benzinga
The Law Offices of Frank R. Cruz Announces Investigation of AbbVie Inc. (ABBV) on Behalf of Investors
April 10, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade
April 09, 2024
Income-seeking investors can look forward to steady payout raises from these pharma stocks.
Via
The Motley Fool
3 No-Brainer Dividend Stocks to Buy in April
April 06, 2024
Income investors will find a lot to like about these stocks.
Via
The Motley Fool
Passive Income Perfection: 7 Dividend Stocks to Generate $50,000 Per Year
April 04, 2024
These seven dividend stocks provide a base for $50,000 in income per year for dedicated investors with patience.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
April 03, 2024
Via
Benzinga
FibroGen Unveils Early Data From Prostate Cancer Candidate, Analyst Advocates Further Exploration In The Landscape
April 03, 2024
FibroGen reveals Phase 1 results for FG-3246 for metastatic castration-resistant prostate cancer. Promising efficacy metrics and plans for enhanced therapeutic strategies signal potential advancements...
Via
Benzinga
The 3 Best Stocks to Buy in April 2024
April 02, 2024
With market dynamics shifting in the wind, concerned investors may want to target these ideas for best stocks to buy in April.
Via
InvestorPlace
Roivant Sciences Stock Flirts With Breakout On 'Extremely Positive' Eye-Disease Study
April 02, 2024
The company hopes to treat noninfectious uveitis and is rivaling AbbVie's Humira.
Via
Investor's Business Daily
Got $3,000? 2 Monster Growth Stocks to Buy Right Now Without Hesitation
April 02, 2024
These stocks can deliver powerhouse portfolio growth in the years ahead.
Via
The Motley Fool
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AdTheorent Holding Company, Inc. (Nasdaq – ADTH), Agiliti, Inc. (NYSE – AGTI), Landos Biopharma, Inc. (Nasdaq – LABP), Fusion Pharmaceuticals Inc. (Nasdaq - FUSN)
April 01, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
Meet The "Magnificent Seven" of Healthcare Stocks
April 01, 2024
The tech sector doesn't have a monopoly on magnificent corporations.
Via
The Motley Fool
3 Reliable Dividend Growth Stocks With Yields Above 3% That You Can Buy Now and Hold for at Least a Decade
March 30, 2024
These advantaged businesses have what it takes to keep raising their payouts.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
March 28, 2024
Via
Benzinga
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
March 28, 2024
The FDA has delayed making a decision on Eli Lilly's donanemab, pending an advisory committee meeting.
Via
Investor's Business Daily
Exposures
Product Safety
Long Live the Dividend Kings: 3 Top Picks to Build an Income Portfolio
March 28, 2024
The dividend kings are excellent stocks with which to establish an income portfolio with these three dividend king stocks standing out.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
60
61
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.